BMJ Open 7 , e015735 (2017)
Retatrutide is best suited for patients with significant obesity (BMI 35), severe metabolic resistance, conditions such as type 2 diabetes, metabolic syndrome, or NAFLD, or those who have tried semaglutide or tirzepatide without adequate results and need the most advanced pharmacological metabolic support available as a non-surgical option
Some approximate equivalencies have emerged from clinical observation, though these should guide rather than dictate dosing decisions
The shipping is free for all orders over $750
While Wegovy and Mounjaro are now available on the NHS, strict eligibility criteria and ongoing supply issues mean that access remains limited for many
Bei einem Rezept mit 6 Medikamentenpackungen mit Maximalbonus sind das bis zu 30 Sparvorteil